Exazyme leverages advanced AI/ML tools to streamline protein design in the most efficient and effective way.
Exazyme has raised $2.2M in total funding. The most recent round was Seed. The last funding was announced in May 2023.
Exazyme's investors include AIX Ventures, IBB Ventures, Atlantic.
Exazyme is headquartered in Berlin, Germany.
Exazyme leverages advanced AI/ML tools to streamline protein design in the most efficient and effective way.
Exazyme is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Exazyme — Funding & Investors." VCBacked, May 15, 2023, https://www.vcbacked.co/company/exazyme. Accessed July 19, 2026.
VCBacked. (2023). Exazyme — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/exazyme
{{cite web |title=Exazyme — Funding & Investors |url=https://www.vcbacked.co/company/exazyme |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated